Liisa Määttänen

8.9k total citations
55 papers, 1.6k citations indexed

About

Liisa Määttänen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Liisa Määttänen has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 14 papers in Surgery. Recurrent topics in Liisa Määttänen's work include Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (41 papers) and Global Cancer Incidence and Screening (13 papers). Liisa Määttänen is often cited by papers focused on Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (41 papers) and Global Cancer Incidence and Screening (13 papers). Liisa Määttänen collaborates with scholars based in Finland, Netherlands and Sweden. Liisa Määttänen's co-authors include Anssi Auvinen, Teuvo L.J. Tammela, Ulf‐Håkan Stenman, Harri Juusela, S. Rannikko, Matti Hakama, Teemu J. Murtola, Jussi Aro, Patrik Finne and Monique J. Roobol and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

In The Last Decade

Liisa Määttänen

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liisa Määttänen Finland 25 1.2k 506 334 307 238 55 1.6k
Siu‐Long Yao United States 18 1.0k 0.8× 700 1.4× 269 0.8× 483 1.6× 459 1.9× 43 2.0k
Yasuhide Miyoshi Japan 24 1.0k 0.8× 593 1.2× 437 1.3× 281 0.9× 402 1.7× 137 2.0k
Jesco Pfitzenmaier Germany 21 753 0.6× 390 0.8× 265 0.8× 277 0.9× 541 2.3× 58 1.6k
Jie Jin China 24 849 0.7× 375 0.7× 296 0.9× 310 1.0× 676 2.8× 103 1.7k
Andreas Pettersson Sweden 24 803 0.7× 334 0.7× 563 1.7× 348 1.1× 547 2.3× 62 1.8k
Paul Toren Canada 19 681 0.6× 228 0.5× 235 0.7× 272 0.9× 425 1.8× 77 1.2k
Marian Loffredo United States 27 2.7k 2.2× 370 0.7× 441 1.3× 269 0.9× 141 0.6× 82 3.0k
Alex Smith United States 16 1.0k 0.8× 595 1.2× 552 1.7× 400 1.3× 641 2.7× 21 2.1k
Jacques Planas Spain 22 1.2k 1.0× 330 0.7× 165 0.5× 272 0.9× 330 1.4× 137 1.6k
Takashi Imamoto Japan 24 911 0.7× 255 0.5× 343 1.0× 175 0.6× 361 1.5× 64 1.5k

Countries citing papers authored by Liisa Määttänen

Since Specialization
Citations

This map shows the geographic impact of Liisa Määttänen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liisa Määttänen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liisa Määttänen more than expected).

Fields of papers citing papers by Liisa Määttänen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liisa Määttänen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liisa Määttänen. The network helps show where Liisa Määttänen may publish in the future.

Co-authorship network of co-authors of Liisa Määttänen

This figure shows the co-authorship network connecting the top 25 collaborators of Liisa Määttänen. A scholar is included among the top collaborators of Liisa Määttänen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liisa Määttänen. Liisa Määttänen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murtola, Teemu J., Kirsi Talala, Liisa Määttänen, et al.. (2016). Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer. European Urology Focus. 3(2-3). 212–220. 44 indexed citations
2.
Murtola, Teemu J., Liisa Määttänen, Kirsi Talala, et al.. (2015). Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial. Cancer Causes & Control. 27(2). 157–164. 11 indexed citations
3.
Murtola, Teemu J., Liisa Määttänen, Kimmo Taari, Teuvo L.J. Tammela, & Anssi Auvinen. (2014). PD31-03 STATIN USE AND SURVIVAL AFTER PROSTATE CANCER DIAGNOSIS IN THE FINNISH PROSTATE CANCER SCREENING TRIAL. The Journal of Urology. 191(4S). 2 indexed citations
4.
Vasarainen, Hanna, Liisa Määttänen, Mirja Ruutu, et al.. (2013). Effects of prostate cancer screening on health-related quality of life: Results of the Finnish arm of the European randomized screening trial (ERSPC). Acta Oncologica. 52(8). 1615–1621. 21 indexed citations
5.
Kilpeläinen, Tuomas P., Teuvo L.J. Tammela, Nea Malila, et al.. (2013). Prostate Cancer Mortality in the Finnish Randomized Screening Trial. JNCI Journal of the National Cancer Institute. 105(10). 719–725. 83 indexed citations
6.
Schröder, Fritz H., Jonas Hugosson, Sigrid Carlsson, et al.. (2012). Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). European Urology. 62(5). 745–752. 182 indexed citations
7.
Rissanen, Pekka, et al.. (2012). Health-Related Quality of Life in the Finnish Trial of Screening for Prostate Cancer. European Urology. 65(1). 39–47. 20 indexed citations
8.
Wu, Grace Hui‐Min, Anssi Auvinen, Liisa Määttänen, et al.. (2011). Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening. International Journal of Cancer. 131(6). 1367–1375. 16 indexed citations
9.
Roobol, Monique J., Ries Kranse, Liisa Määttänen, et al.. (2010). Prediction of prostate cancer in unscreened men: External validation of a risk calculator. European Journal of Cancer. 47(6). 903–909. 50 indexed citations
10.
Kilpeläinen, Tuomas P., Teuvo L.J. Tammela, Liisa Määttänen, et al.. (2010). False-positive screening results in the Finnish prostate cancer screening trial. British Journal of Cancer. 102(3). 469–474. 35 indexed citations
11.
Murtola, Teemu J., Teuvo L.J. Tammela, Liisa Määttänen, et al.. (2010). Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial. International Journal of Cancer. 127(7). 1650–1659. 84 indexed citations
12.
Murtola, Teemu J., Teuvo L.J. Tammela, Liisa Määttänen, et al.. (2009). Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial. British Journal of Cancer. 101(5). 843–848. 46 indexed citations
13.
Finne, Patrik, Anssi Auvinen, Liisa Määttänen, et al.. (2007). Diagnostic Value of Free Prostate-Specific Antigen among Men with a Prostate-Specific Antigen Level of <3.0μg per Liter. European Urology. 54(2). 362–370. 34 indexed citations
14.
Murtola, Teemu J., Teuvo L.J. Tammela, Liisa Määttänen, Matti Hakama, & Anssi Auvinen. (2007). Prostate cancer risk among users of finasteride and alpha-blockers – A population based case–control study. European Journal of Cancer. 43(4). 775–781. 10 indexed citations
15.
Roobol, Monique J., Marco Zappa, Liisa Määttänen, & Stefano Ciatto. (2006). The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC). The Prostate. 67(4). 439–446. 22 indexed citations
16.
Tammela, Teuvo L.J., et al.. (2006). SERUM LIPID-LOWERING DRUGS AND PROSTATE CANCER RISK – A POPULATION BASED CASE-CONTROL STUDY. European Urology Supplements. 5(2). 316–316. 3 indexed citations
17.
Finne, Patrik, Ulf‐Håkan Stenman, Liisa Määttänen, et al.. (2003). The Finnish trial of prostate cancer screening: where are we now?. British Journal of Urology. 92(s2). 22–26. 33 indexed citations
18.
Isola, Jorma, Anssi Auvinen, Laura Kakkola, et al.. (2001). PREDICTORS OF BIOLOGICAL AGGRESSIVENESS OF PROSTATE SPECIFIC ANTIGEN SCREENING DETECTED PROSTATE CANCER. The Journal of Urology. 165(5). 1569–1574. 9 indexed citations
19.
Finne, Patrik, Anssi Auvinen, Harri Juusela, et al.. (2000). Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology. 56(3). 418–422. 122 indexed citations
20.
Finne, Patrik, Wanming Zhang, Anssi Auvinen, et al.. (2000). Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.. PubMed. 164(6). 1956–60. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siu‐Long Yao Breakdown of academic impact, for papers by Yasuhide Miyoshi Breakdown of academic impact, for papers by Jesco Pfitzenmaier Breakdown of academic impact, for papers by Jie Jin Breakdown of academic impact, for papers by Andreas Pettersson Breakdown of academic impact, for papers by Paul Toren Breakdown of academic impact, for papers by Marian Loffredo Breakdown of academic impact, for papers by Alex Smith Breakdown of academic impact, for papers by Jacques Planas Breakdown of academic impact, for papers by Takashi Imamoto
Rankless by CCL
2026